Lipton S A, Stamler J S
Department of Neurology, Children's Hospital, Boston, MA.
Neuropharmacology. 1994 Nov;33(11):1229-33. doi: 10.1016/0028-3908(94)90021-3.
The local redox milieu of a biological system is of critical importance in understanding the actions of the nitrogen monoxide (NO) moiety, as disparate chemical pathways involving distinct redox-related congeners of NO may trigger neurotoxic or neuroprotective pathways. The reactions of nitric oxide (NO.) with superoxide can lead to neurotoxicity through formation of peroxynitrite, whereas NO. alone does not, at least under certain conditions. Reaction (or transfer) of NO+ equivalents to thiol(s) on the NMDA receptor can lead to neuroprotection by inhibiting Ca2+ influx. These findings suggest that cell function can be controlled by, or through, protein S-nitrosylation, and raise the possibility that the NO group may initiate signal transduction in or at the plasma membrane. Neuroprotective effects of NO- suggest that acceleration of disulfide bond formation at the NMDA receptor is of mechanistic importance in the attenuation of Ca2+ influx. Our findings suggest novel therapeutic strategies. For example, downregulation of NMDA receptor activity can be obtained via sulfhydryl oxidation by S-nitros(yl)ation with NO+ donors (to form an RSNO at a cysteine residue on the receptor), or with NO- donors (with intermediate formation of RSNHOH). Pharmacologic intervention with these forms of NO donors could be implemented in the treatment of focal ischemia, neuropathic pain, Huntington's disease, AIDS dementia, and other neurological disorders associated, at least in part, with excessive activation of NMDA receptors.
生物系统的局部氧化还原环境对于理解一氧化氮(NO)部分的作用至关重要,因为涉及不同氧化还原相关的NO同系物的不同化学途径可能触发神经毒性或神经保护途径。一氧化氮(NO·)与超氧化物的反应可通过过氧亚硝酸盐的形成导致神经毒性,而单独的NO·至少在某些条件下不会。NO+等价物与NMDA受体上的硫醇反应可通过抑制Ca2+内流导致神经保护。这些发现表明细胞功能可以通过蛋白质S-亚硝基化来控制或通过其来实现,并增加了NO基团可能在质膜内或质膜处启动信号转导的可能性。NO-的神经保护作用表明,NMDA受体处二硫键形成的加速在Ca2+内流的减弱中具有重要机制意义。我们的发现提示了新的治疗策略。例如,可通过用NO+供体进行S-亚硝基化(在受体上的半胱氨酸残基处形成RSNO)或用NO-供体(中间形成RSNHOH)进行巯基氧化来下调NMDA受体活性。用这些形式的NO供体进行药物干预可用于治疗局灶性缺血、神经性疼痛、亨廷顿舞蹈病、艾滋病痴呆以及其他至少部分与NMDA受体过度激活相关的神经疾病。